| Literature DB >> 31884559 |
Quan Li1,2, Jian Yin1,2, Zheng Li1,2, Zewei Li1,2, Yuanzhao Du3, Weiwei Guo3, Matthew Bellefleur4, Shifeng Wang4, Huoying Shi5,6,7,8.
Abstract
Salmonella is an important food-borne pathogen associated with public health and high economic losses. To investigate the prevalence and the characteristics of Salmonella in a pig slaughterhouse in Yangzhou, a total of 80 Salmonella isolates were isolated from 459 (17.43%) samples in 2016-2017. S. Derby (35/80, 43.75%) was the most prevalent, followed by S. Rissen (16/80, 20.00%) and S. Newlands (11/80, 13.75%). The highest rates of susceptibility were observed to cefoxitin (80/80, 100.0%) and amikacin (80/80, 100.0%), followed by aztreonam (79/80, 98.75%) and nitrofurantoin (79/80, 98.75%). The highest resistance rate was detected for tetracycline (65/80, 81.25%), followed by ampicillin (60/80, 75.00%), bactrim (55/80, 68.75%), and sulfisoxazole (54/80, 67.50%). Overall, 91.25% (73/80) of the isolates were resistant to at least one antibiotic, while 71.25% (57/80) of the isolate strains were multidrug resistant in the antimicrobial susceptibility tested. In addition, 86.36% (19/22) of the 22 antimicrobial resistance genes in the isolates were identified. Our data indicated that the resistance to certain antimicrobials was significantly associated, in part, with antimicrobial resistance genes. Furthermore, 81.25% (65/80) isolates harbored the virulence gene of mogA, of which 2 Salmonella Typhimurium isolates carried the mogA, spvB and spvC virulence genes at the same time. The results showed that swine products in the slaughterhouse were contaminated with multidrug resistant Salmonella commonly, especially some isolates carry the spv virulence genes. The virulence genes might facilitate the dissemination of the resistance genes to consumers along the production chain, suggesting the importance of controlling Salmonella during slaughter for public health.Entities:
Keywords: Antimicrobial resistance genes; Antimicrobial susceptibility; Pig slaughterhouse; Salmonella; Virulence genes
Year: 2019 PMID: 31884559 PMCID: PMC6935380 DOI: 10.1186/s13568-019-0936-9
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Primers used for PCR amplification
| Target genes | Nucleotide sequences | Size (bp) |
|---|---|---|
| | 5′-CTTTGGTCGTAAAATAAGGCG-3′ | 260 |
| | 5′-TGCCCAAAGCAGAGAGATTC-3′ | |
| | 5′-ACTGGCGTTATCCCTTTCTCTGCTG-3′ | 495 |
| | 5′-ATGTTGTCCTGCCCCTGGTAAGAGA-3′ | |
| 16S rRNA primer set | ||
| 27F | 5′-AGAGTTTGATCCTGGCTCAG-3′ | 1466 |
| 1492R | 5′-TACGGTTACCTTGTTACGACTT-3′ | |
| Antimicrobial resistance gene primer sets | ||
| Quinolones | ||
| 5′-TTCAGCAAGAGGATTTCTCA-3′ | 500 | |
| 5′-GGCAGCACTATTACTCCCAA -3′ | ||
| 5′-CCTGAGCGGCACTGAATTTT-3′ | 617 | |
| 5′-GTTTGCTGCTCGCCAGTCGA-3′ | ||
| 5′-GGGTTGTACATTTATTGAATC-3′ | 447 | |
| 5′-TCCACTTTACGAGGTTCT-3′ | ||
| 5′-TTACGGGGAATAGAGTTA-3′ | 468 | |
| 5′-AATCAGCCAAAGACCAAT-3′ | ||
| 5′-ACATAAAGACTTAAGTGATC-3′ | 619 | |
| 5′-CAATTAGTCAGGATAAAC-3′ | ||
| 5′-CCAGCTCGGCAACTTGATAC-3′ | 570 | |
| 5′-ATGCTCGCCTTCCAGAAAA-3′ | ||
| 5′-CTCGGCGCGATGATGCTC-3′ | 392 | |
| 5′-CACTCTTCACGGGAGACGA-3′ | ||
| 5′-TTCTCCCCCGGGGGGAAGTCCTCGGC-3′ | 512 | |
| 5′-CATTTTGGCGCGTA-3′ | ||
| Aminoglycosides | ||
| 5′-TTGCGATGCTCTATGAGTGGCTA-3′ | 482 | |
| 5′-CTCGAATGCCTGGCGTGTT-3′ | ||
| 5′-GCGCCATCTCGAACCGACGTT-3′ | 573 | |
| 5′-GCCCAGTCGGCAGCGACATC-3′ | ||
| Sulfonamides | ||
| 5′-TGGCGTCGCGACTGCGAAAT-3′ | 813 | |
| 5′-TGGTGACGGTGTTCGGCATTCT-3′ | ||
| 5′-GTTTCTCCGATGGAGGCCGGT-3′ | 517 | |
| 5′-AGCGAGGTTTCGGGAGCAGC-3′ | ||
| Trimethoprim | ||
| 5′-AGTGCCAAAGGTGAACAGCTCCT-3′ | 308 | |
| 5′-ACATCACCTTCCGGCTCGATGTCT-3′ | ||
| β-lactamase | ||
| 5′-ATGAAAAACACAATACATATC-3′ | 830 | |
| 5′-AATTTAGTGTGTTTAGAATGG-3′ | ||
| 5′-CGCTTCCCGTTAACAAGTAC-3′ | 420 | |
| 5′-CTGGTTCATTTCAGATAGCG-3′ | ||
| 5′-ATAAAATTCTTGAAGACGAAA-3′ | 1080 | |
| 5′-GACAGTTACCAATGCTTAATC-3′ | ||
| 5′-TGGCGGTTGCCGTTATCTAC-3′ | 210 | |
| 5′-CCCGTTTTATGCACCCATGA-3′ | ||
| Tetracyclines | ||
| 5′-TGGTCCGGAGGCCAGACGTG-3′ | 867 | |
| 5′-TTCCGAGCATGAGTGCCCGC-3′ | ||
| 5′-GGAGCTACTGGGGCTGTCGCACC-3′ | 374 | |
| 5′-ACCCACACCGTTGCGGGAAT-3′ | ||
| 5′-TCTTGCAGGAGCCGCAGTCGAT-3′ | 721 | |
| 5′-GGCCGGCATGCCAACACCC-3′ | ||
| Chloramphenicols | ||
| 5′-TCTTGCCCGCCTGATGAATGC-3′ | 388 | |
| 5′-AACCTGAATCGCCAGCGGCA-3′ | ||
| 5′-AACCCGCCCTCTGGATCAAGTCAA-3′ | 549 | |
| 5′-CAAATCACGGGCCACGCTGTATC-3′ | ||
| Virulence gene primer sets | ||
| | 5′-ATTGGCTTAGTTTCTATCTCCG-3′ | 419 |
| | 5′-CCTTCCAGCGTTTCTTTGA-3′ | |
| 5′-CCGTAGAGCAGACGCTGTAAGC-3′ | 1856 | |
| | 5′-GTATCTATGAGTTGAGTACCCCTATG-3′ | |
| | 5′-CCGCAAAGTAGTGCATCTAAAC-3′ | 919 |
| | 5′-CCATACTTACTCTGTCATCAAACG-3′ | |
Information of Salmonella isolated from a pig slaughterhouse in Yangzhou, China
| No. | Serotype | Origin | Virulence genes | Resistance genes | Date | ||
|---|---|---|---|---|---|---|---|
| 1 | Feces | − | − | − | 2 Oct 2016 | ||
| 2 | Liver | + | + | + | 2 Oct 2016 | ||
| 3 | Ileum | + | + | + | 2 Oct 2016 | ||
| 4 | Ileum | + | − | − | 2 Oct 2016 | ||
| 5 | Ileum | + | − | − | 2 Oct 2016 | ||
| 6 | Liver | + | − | − | 22 Oct 2016 | ||
| 7 | Liver | + | − | − | 23 Oct 2016 | ||
| 8 | Ileum | + | − | − | 23 Oct 2016 | ||
| 9 | Liver | − | − | − | 23 Oct 2016 | ||
| 10 | Liver | + | − | − | 23 Oct 2016 | ||
| 11 | Liver | + | − | − | 4 Dec 2016 | ||
| 12 | Ileum | − | − | − | 4 Dec 2016 | ||
| 13 | Ileum | − | − | − | 4 Dec 2016 | ||
| 14 | Ileum | − | − | − | 4 Dec 2016 | ||
| 15 | Ileum | + | − | − | 4 Dec 2016 | ||
| 16 | Ileum | + | − | − | 4 Dec 2016 | ||
| 17 | Ileum | + | − | − | 10 Dec 2016 | ||
| 18 | Ileum | + | − | − | 10 Dec 2016 | ||
| 19 | Ileum | + | − | − | 10 Dec 2016 | ||
| 20 | Ileum | + | − | − | 10 Dec 2016 | ||
| 21 | Ileum | + | − | − | 10 Dec 2016 | ||
| 22 | Ileum | − | − | − | 10 Dec 2016 | ||
| 23 | Ileum | − | − | − | 10 Dec 2016 | ||
| 24 | Liver | + | − | − | 26 Dec 2016 | ||
| 25 | Feces | − | − | − | 26 Dec 2016 | ||
| 26 | Ileum | + | − | − | 26 Dec 2016 | ||
| 27 | Ileum | + | − | − | 26 Dec 2016 | ||
| 28 | Ileum | + | − | − | 26 Dec 2016 | ||
| 29 | Ileum | + | − | − | 26 Dec 2016 | ||
| 30 | Liver | + | − | − | 14 Jan 2017 | ||
| 31 | Liver | + | − | − | 14 Jan 2017 | ||
| 32 | Liver | + | − | − | 14 Jan 2017 | ||
| 33 | Ileum | − | − | − | 14 Jan 2017 | ||
| 34 | Ileum | − | − | − | 25 Feb 2017 | ||
| 35 | Ileum | − | − | − | 25 Feb 2017 | ||
| 36 | Ileum | + | − | − | 25 Feb 2017 | ||
| 37 | Ileum | − | − | − | 25 Feb 2017 | ||
| 38 | Ileum | + | − | − | 25 Feb 2017 | ||
| 39 | Ileum | + | − | − | 25 Feb 2017 | ||
| 40 | Ileum | + | − | − | 25 Feb 2017 | ||
| 41 | Ileum | − | − | − | 25 Feb 2017 | ||
| 42 | Liver | + | − | − | 2 Apr 2017 | ||
| 43 | Ileum | + | − | − | 2 Apr 2017 | ||
| 44 | Liver | + | − | − | 22 Apr 2017 | ||
| 45 | Ileum | + | − | − | 22 Apr 2017 | ||
| 46 | Ileum | + | − | − | 22 Apr 2017 | ||
| 47 | Ileum | − | − | − | 22 Apr 2017 | ||
| 48 | Ileum | + | − | − | 22 Apr 2017 | ||
| 49 | Ileum | + | − | − | 22 Apr 2017 | ||
| 50 | Ileum | + | − | − | 22 Apr 2017 | ||
| 51 | Ileum | + | − | − | 22 Apr 2017 | ||
| 52 | Ileum | + | − | − | 22 Apr 2017 | ||
| 53 | Ileum | + | − | − | 22 Apr 2017 | ||
| 54 | Ileum | + | − | − | 22 Apr 2017 | ||
| 55 | Ileum | + | − | − | 22 Apr 2017 | ||
| 56 | Ileum | + | − | − | 22 Apr 2017 | ||
| 57 | Ileum | + | − | − | 22 Apr 2017 | ||
| 58 | Ileum | + | − | − | 22 Apr 2017 | ||
| 59 | Ileum | + | − | − | 22 Apr 2017 | ||
| 60 | Liver | + | − | − | 20 May 2017 | ||
| 61 | Ileum | + | − | − | 20 May 2017 | ||
| 62 | Ileum | + | − | − | 20 May 2017 | ||
| 63 | Untyped | Ileum | + | − | − | 20 May 2017 | |
| 64 | Ileum | + | − | − | 17 Jul 2017 | ||
| 65 | Ileum | + | − | − | 17 Jul 2017 | ||
| 66 | Ileum | + | − | − | 20 Oct 2017 | ||
| 67 | Ileum | + | − | − | 20 Oct 2017 | ||
| 68 | Ileum | + | − | − | 20 Oct 2017 | ||
| 69 | Ileum | + | − | − | 20 Oct 2017 | ||
| 70 | Liver | + | − | − | 22 Oct 2017 | ||
| 71 | Ileum | + | − | − | 22 Oct 2017 | ||
| 72 | Ileum | − | − | − | 22 Oct 2017 | ||
| 73 | Ileum | + | − | − | 22 Oct 2017 | ||
| 74 | Ileum | + | − | − | 22 Oct 2017 | ||
| 75 | Ileum | + | − | − | 22 Oct 2017 | ||
| 76 | Ileum | + | − | − | 22 Oct 2017 | ||
| 77 | Ileum | + | − | − | 22 Oct 2017 | ||
| 78 | Ileum | + | − | − | 28 Oct 2017 | ||
| 79 | Ileum | + | − | − | 28 Oct 2017 | ||
| 80 | Ileum | + | − | − | 28 Oct 2017 | ||
Serotype distribution of the Salmonella isolates
| Groups of sero-group of | Serotype of | Numbers of isolates |
|---|---|---|
| Group B | 35 | |
| 9 | ||
| 2 | ||
| Group C1 | 16 | |
| Group E1 | 11 | |
| 3 | ||
| 3 | ||
| Untyped | 1 |
Fig. 1Phylogenetic tree of 80 Salmonella isolates based on 16S rRNA analysis. 16S rRNA gene sequences (1466 bp) were amplified by PCR and the nucleotide sequences determined. This is a neighbour-joining tree based on 80 Salmonella 16S rRNA sequences. The scale bar indicates one base substitution per 10,000 nt position. The number shown next to each node indicates the bootstrap value (1000 replicates)
Antimicrobial resistance rates of the 80 Salmonella isolates
| Antimicrobials | Susceptible | Intermediate | Resistant |
|---|---|---|---|
| Ampicillin | 6 (7.50%) | 14 (17.50%) | 60 (75.00%) |
| Mezlocillin | 40 (50.00%) | 30 (37.50%) | 10 (12.50%) |
| Augmentin | 52 (65.00%) | 6 (7.50%) | 22 (27.50%) |
| Ceftriaxone | 68 (85.00%) | 12 (15.00%) | 0 (0.00%) |
| Cefoxitin | 80 (100.00%) | 0 (0.00%) | 0 (0.00%) |
| Aztreonam | 79 (98.75%) | 1 (1.25%) | 0 (0.00%) |
| Polymyxin B | 49 (61.25%) | 31 (38.75%) | 0 (0.00%) |
| Gentamicin | 64 (80.00%) | 3 (3.75%) | 13 (16.25%) |
| Tobramycin | 65 (81.25%) | 3 (3.75%) | 12 (15.00%) |
| Amikacin | 80 (100.00%) | 0 (0.00%) | 0 (0.00%) |
| Kanamycin | 64 (80.00%) | 4 (5.00%) | 12 (15.00%) |
| Neomycin | 70 (87.50%) | 0 (0.00%) | 10 (12.50%) |
| Streptomycin | 31 (38.75%) | 26 (32.50%) | 23 (28.75%) |
| Tetracycline | 14 (17.50%) | 1 (1.25%) | 65 (81.25%) |
| Florfenicol | 46 (57.50%) | 4 (5.00%) | 30 (37.50%) |
| Ciprofloxacin | 55 (68.75%) | 17 (21.25%) | 8 (10.00%) |
| Enrofloxacin | 25 (31.25%) | 44 (55.00%) | 11 (13.75%) |
| Bactrim | 25 (31.25%) | 0 (0.00%) | 55 (68.75%) |
| Sulfisoxazole | 21 (26.25%) | 5 (6.25%) | 54 (67.50%) |
| Chloramphenicol | 41 (51.25%) | 2 (2.50%) | 37 (46.25%) |
| Nitrofurantoin | 79 (98.75%) | 1 (1.25%) | 0 (0.00%) |
| Trimethoprim | 49 (61.25%) | 7 (8.75%) | 24 (30.00%) |
Antimicrobial resistance phenotypes of the 80 Salmonella isolates
| Resistant phenotypes (numbers) | Numbers of isolates |
|---|---|
| AMP | 5 |
| STR | 1 |
| TET | 3 |
| FFC | 1 |
| AMP-TET | 2 |
| TET-SUL | 2 |
| TET-SXT | 2 |
| TET-SXT-SUL | 1 |
| AMP-TET-SXT | 1 |
| AMP-TET-SXT-SUL | 2 |
| STR-TET-SXT-TMP | 1 |
| TET-CHL-SXT-SUL | 1 |
| AMP-TET-SXT-SUL-TMP | 4 |
| AMP-MEZ-TET-SXT-SUL-TMP | 1 |
| AMP-AMC-TET-SXT | 1 |
| AMP-KAN-TET-CHL | 2 |
| AMP-AMC-TET-SXT-SUL | 1 |
| AMP-TET-CHL-SXT-SUL | 1 |
| AMP-MEZ-AMC-TET-SXT-SUL | 1 |
| AMP-STR-TET-SXT-SUL-TMP | 5 |
| AMP-TET-CHL-FFC-SXT-SUL | 2 |
| AMP-TET-CHL-SXT-SUL-TMP | 1 |
| STR-TET-CHL-FFC-SXT-SUL | 1 |
| AMP-MEZ-STR-TET-SXT-SUL-TMP | 1 |
| AMP-TET-CHL-FFC-SXT-SUL-TMP | 1 |
| AMP-AMC-TET-CHL-FFC-SXT-SUL | 3 |
| AMP-STR-TET-FFC-SXT-SUL-TMP | 1 |
| AMP-GEN-STR-TET-CHL-FFC-SXT-SUL | 1 |
| AMP-MEZ-AMC-TET-CHL-FFC-SXT-SUL | 3 |
| AMP-NEO-STR-TET-CHL-SXT-SUL-TMP | 1 |
| AMP-STR-TET-CHL-FFC-SXT-SUL-TMP | 3 |
| AMP-GEN-STR-TET-CHL-FFC-SXT-SUL-TMP | 1 |
| AMP-MEZ-STR-TET-CHL-FFC-SXT-SUL-TMP | 1 |
| AMP-AMC-GEN-TOB-KAN-STR-CHL-FFC-SXT-SUL | 1 |
| AMP-AMC-STR-TET-CHL-SXT-SUL | 1 |
| AMP-AMC-GEN-STR-TET-CHL-SXT-SUL | 1 |
| AMP-MEZ-AMC-TET-CHL-FFC-ENR-SUL | 1 |
| AMP-MEZ-GEN-TOB-STR-TET-CHL-FFC-CIP-ENR-SUL | 1 |
| AMP-GEN-TOB-KAN-NEO-STR-TET-CHL-FFC-CIP-ENR-SXT-SUL-TMP | 1 |
| AMP-AMC-GEN-TOB-STR-TET-CHL-ENR-SXT-SUL | 1 |
| AMP-AMC-TOB-KAN-NEO-TET-CHL-FFC-CIP-SXT-SUL | 1 |
| AMP-AMC-GEN-TOB-KAN-NEO-TET-CHL-FFC-ENR-SXT-SUL | 1 |
| AMP-AMC-GEN-TOB-KAN-NEO-TET-CHL-FFC-CIP-ENR-SXT-SUL | 3 |
| AMP-AMC-TOB-KAN-NEO-TET-CHL-FFC-CIP-ENR-SXT-SUL-TMP | 1 |
| AMP-MEZ-AMC-GEN-TOB-KAN-NEO-TET-CHL-FFC-ENR-SXT-SUL | 1 |
| AMP-AMC-GEN-TOB-KAN-NEO-TET-CHL-FFC-CIP-ENR-SXT-SUL-TMP | 1 |
Antimicrobial resistance genes of the Salmonella isolates
| Drug classes | Resistance genes | Number of isolates | Positive rates (%) |
|---|---|---|---|
Quinolones 40.00% | 0 | 0.00 | |
| 1 | 1.25 | ||
| 0 | 0.00 | ||
| 0 | 0.00 | ||
| 5 | 6.25 | ||
| 4 | 5.00 | ||
| 14 | 17.50 | ||
| 9 | 11.25 | ||
Aminoglycosides 51.25% | 16 | 20.00 | |
| 33 | 41.25 | ||
Sulfonamides 27.50% | 8 | 10.00 | |
| 21 | 26.25 | ||
β-lactamase 43.75% | 9 | 11.25 | |
| 8 | 10.00 | ||
| 20 | 25.00 | ||
| 1 | 1.25 | ||
Tetracyclines 73.75% | 51 | 63.75 | |
| 6 | 7.50 | ||
| 6 | 7.50 | ||
Chloramphenicols 60.00% | 38 | 47.50 | |
| 22 | 27.50 | ||
Trimethoprim 15.00% | 12 | 15.00 |
Resistance genes and phenotype relationship of Salmonella isolates
| Drug classes | Quinolones | Aminoglycosides | Folate pathway inhibitors | β-lactamase | Tetracyclines | Chloramphenicols | ||
|---|---|---|---|---|---|---|---|---|
| Ciprofloxacin | Gentamicin, Tobramycin | Sulfonamides | Trimethoprim | Penicillins | Cephalosporins | Tetracycline | Chloramphenicol | |
| Resistance genes | ||||||||
| Number of isolates carrying drug-resistant genes | 23 | 41 | 22 | 12 | 34 | 1 | 59 | 48 |
| Number of drug-resistant isolates | 12 | 33 | 59 | 24 | 60 | 0 | 65 | 39 |